1,009 reports of this reaction
3.4% of all EZETIMIBE AND SIMVASTATIN reports
#1 most reported adverse reaction
NAUSEA is the #1 most commonly reported adverse reaction for EZETIMIBE AND SIMVASTATIN, manufactured by Organon LLC. There are 1,009 FDA adverse event reports linking EZETIMIBE AND SIMVASTATIN to NAUSEA. This represents approximately 3.4% of all 29,702 adverse event reports for this drug.
Patients taking EZETIMIBE AND SIMVASTATIN who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among EZETIMIBE AND SIMVASTATIN users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for EZETIMIBE AND SIMVASTATIN:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,009 FDA reports for EZETIMIBE AND SIMVASTATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.4% of all adverse event reports for EZETIMIBE AND SIMVASTATIN, making it one of the most commonly reported side effect.
If you experience nausea while taking EZETIMIBE AND SIMVASTATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.